Cybersecurity Threats to Clinical Trial Data Sharing
Clinical trials are an essential part of drug development and are crucial in determining the safety and efficacy of new treatments. The sharing of clinical trial data is also crucial for promoting transparency, accountability, and trust in the clinical research process. However, as the world becomes more connected, the risk of sensitive data being compromised is a growing concern. Cybersecurity threats are a prime example of such risks. Cyberattacks pose a serious threat to clinical trial data sharing, and without adequate protection, the consequences could be dire.
This article aims to explore the various cybersecurity threats that clinical trial data sharing faces and the measures that can be taken to minimize the risks associated with them.
1. Insider Threats
Insider threats are one of the most significant cybersecurity risks to clinical trial data sharing. A study by Ponemon Institute in 2016 found that 59% of data breaches in healthcare were caused by insiders. Insiders include employees, contractors, or third-party vendors who have access to clinical trial data. These individuals may intentionally or unintentionally expose clinical trial data, and as a result, the data is compromised.
To minimize the risk of insider threats, strict access controls should be implemented. Access to clinical trial data should only be granted to individuals who strictly need the data to perform their job functions. Regular reviews of access levels and logs should also be conducted to ensure that access is revoked for any individuals who no longer require it.
2. Third-Party Risks
Third-party risks are another significant cybersecurity threat to clinical trial data sharing. Clinical trials often involve multiple parties, such as vendors, contract research organizations (CROs), and academic institutions. The involvement of these third parties increases the risk of cyberattacks due to the potential for data exchange.
To minimize risks associated with third-party involvement in clinical trials, contracts should include cybersecurity requirements and measures that must be fulfilled. The contracts should also include contractual warranties and representations made by the third party, which will provide the purchaser of the services some recourse if the third party fails to meet the contractual obligations.
3. Phishing Attacks
Phishing attacks are a popular method used by hackers to gain access to clinical trial data. Phishing attacks involve tricking people into revealing sensitive information, such as login credentials. Hackers can also use phishing attacks to install malware or ransomware onto a computer network.
To minimize the risk of phishing attacks, employees should be trained on how to recognize phishing emails. They should also be required to use strong passwords and multi-factor authentication systems.
Ransomware is a type of malware that encrypts files on a computer network, rendering it inaccessible to those who use it. Cybercriminals will then demand payment in exchange for the decryption key.
To minimize the risk of ransomware attacks, organizations should conduct regular backups of data and create disaster recovery plans. Businesses should also invest in antivirus software and keep the software up to date to ensure that ransomware attacks are detected and prevented.
5. Data Leakage
Data leakage is the accidental or intentional transfer of sensitive data to an unauthorized party. Data leakage can occur when employees accidentally send sensitive information to the incorrect email address or when hackers gain access to data through insecure networks or user credentials.
To minimize the risk of data leakage, organizations should conduct regular audits of data sharing procedures and ensure that employees are trained on best practices for protecting sensitive information. Strict protocols should also be in place to limit the access of sensitive information to essential personnel only.
In conclusion, cybersecurity threats are a significant concern that affects clinical trial data sharing. These threats pose a significant threat to the integrity of clinical trials and could have serious consequences for public health. To minimize the risks associated with cybersecurity threats, organizations should conduct regular assessments of their cybersecurity infrastructure and ensure that all employees are trained on best practices for protecting sensitive information. Continuous monitoring of systems and data backups will also ensure that the organization can respond to any attacks quickly and efficiently. These measures will help to safeguard the integrity and trustworthiness of clinical trial data sharing.
Check out HelpRange
Check out our product HelpRange. It is designed to securely store (GDPR compliant), share, protect,
sell, e-sign and analyze usage of your documents.